Sibel Aylin Ugur Iseri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sibel Aylin Ugur Iseri has a total of 198 co-authors. Here are the top co-authors by number of shared publications:
- Aslıhan Tolun
Faculty of Science and Letters, Istanbul Technical University, Istanbul, Türkiye
9 shared publications Nerses Bebek
Department of Neurology, Istanbul Faculty of Medicine, Istanbul University , Istanbul, 34093
8 shared publications- Ugur Ozbek
Izmir Biomedicine and Genome Center, Izmir, Türkiye
8 shared publications Betul Baykan
Department of Neurology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
5 shared publicationsEmrah Yucesan
Department of Neurogenetics, Institute of Neurological Sciences, Istanbul University-Cerrahpasa, Istanbul, Türkiye
5 shared publicationsBaris Salman
Department of Genetics, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey
4 shared publications
Latest Publications
- Open Access
- 9 October 2026
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 13 (11) , 2395-2399
Generalized Dystonia With Cervical Predominance in a Patient With a De Novo TCF20 Variant
TCF20 has been implicated in developmental delay and intellectual disability, with dystonia reported less frequently. We describe a woman in her early twenties with childhood‐onset learning difficulties, progressive dysarthria, tremor, and generalized dystonia with marked cervical predominance, associated with a de novo TCF20 frameshift variant identified by whole genome sequencing. Quantitative brain MRI demonstrated numerically increased globus pallidus susceptibility and reduced volume compared with controls, without clear evidence of iron accumulation. This case further supports generalized dystonia as a recognizable manifestation of TCF20 ‐related disorders and suggests a possible link between TCF20 dysfunction and globus pallidus involvement in dystonia pathophysiology.
- 9 October 2026
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 13 (11) , 2395-2399
Open AccessGeneralized Dystonia With Cervical Predominance in a Patient With a De Novo TCF20 Variant
TCF20 has been implicated in developmental delay and intellectual disability, with dystonia reported less frequently. We describe a woman in her early twenties with childhood‐onset learning difficulties, progressive dysarthria, tremor, and generalized dystonia with marked cervical predominance, associated with a de novo TCF20 frameshift variant identified by whole genome sequencing. Quantitative brain MRI demonstrated numerically increased globus pallidus susceptibility and reduced volume compared with controls, without clear evidence of iron accumulation. This case further supports generalized dystonia as a recognizable manifestation of TCF20 ‐related disorders and suggests a possible link between TCF20 dysfunction and globus pallidus involvement in dystonia pathophysiology.
- Open Access
- 7 January 2026
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 6 (1)
XhetRel: a pipeline for X heterozygosity and relatedness analysis of sequencing data
Motivation: Verification of sample sex is an essential quality control step in next-generation sequencing studies, typically assessed from genomic data. Clustering individuals by X chromosome heterozygosity (Xhet) and incorporating relatedness estimates offers a practical first-pass screen for potential sex label errors, sample mix-ups, and pedigree inconsistencies. To better interpret Xhet based patterns, we further investigated the biological and technical origins using the 1000 Genomes Project dataset. Results: We developed XhetRel, a user-friendly workflow and notebook application that computes Xhet and performs relatedness estimation directly from VCF files. As a fully genotype-based approach, XhetRel enables both sex-based clustering and relatedness assessment as an initial quality control (QC) step in NGS. XhetRel serves groups without bioinformatics infrastructure, users requiring a browser-based QC tool, and workflow developers seeking a modular Nextflow component. Our investigation into the sources of Xhet variation highlighted important limitations in sequencing and variant-calling approaches. In particular, specific pseudogenes and gene clusters, such as SLC25A5 and the GAGE cluster, as recurrent contributors to misleading variant allele fractions. Availability and implementation: The source code and data are available at Figshare (doi: 10.6084/m9.figshare.28280414). XhetRel can be executed locally via Nextflow or accessed directly through the online Collab notebook at https://colab.research.google.com/drive/1ep69JvXLwK5ndHUQ8qIGTWvauzsTW9fi.
- 7 January 2026
- Published by Oxford University Press (OUP) in Bioinformatics Advances
- Vol. 6 (1)
Open AccessXhetRel: a pipeline for X heterozygosity and relatedness analysis of sequencing data
Motivation: Verification of sample sex is an essential quality control step in next-generation sequencing studies, typically assessed from genomic data. Clustering individuals by X chromosome heterozygosity (Xhet) and incorporating relatedness estimates offers a practical first-pass screen for potential sex label errors, sample mix-ups, and pedigree inconsistencies. To better interpret Xhet based patterns, we further investigated the biological and technical origins using the 1000 Genomes Project dataset. Results: We developed XhetRel, a user-friendly workflow and notebook application that computes Xhet and performs relatedness estimation directly from VCF files. As a fully genotype-based approach, XhetRel enables both sex-based clustering and relatedness assessment as an initial quality control (QC) step in NGS. XhetRel serves groups without bioinformatics infrastructure, users requiring a browser-based QC tool, and workflow developers seeking a modular Nextflow component. Our investigation into the sources of Xhet variation highlighted important limitations in sequencing and variant-calling approaches. In particular, specific pseudogenes and gene clusters, such as SLC25A5 and the GAGE cluster, as recurrent contributors to misleading variant allele fractions. Availability and implementation: The source code and data are available at Figshare (doi: 10.6084/m9.figshare.28280414). XhetRel can be executed locally via Nextflow or accessed directly through the online Collab notebook at https://colab.research.google.com/drive/1ep69JvXLwK5ndHUQ8qIGTWvauzsTW9fi.
- 25 November 2025
- Published by Springer Nature in neurogenetics
- Vol. 26 (1) , 82
Missense variants in PKAN: insights from a multi-patient genetic analysis
- 25 November 2025
- Published by Springer Nature in neurogenetics
- Vol. 26 (1) , 82
Missense variants in PKAN: insights from a multi-patient genetic analysis
- Open Access
XhetRel: A Pipeline for X Heterozygosity and Relatedness Analysis in Sequencing Data
Motivation: Checking sample sex is one of the preliminary controls performed in genetic studies. Comparing multiple individuals and families in terms of sex and relatedness allows us to eliminate systematic errors in downstream analyses. While developing the pipeline we further delved into the origins of X heterozygosity by analysing the chromosome X variants from the 1000 Genomes Project. Result: We created an accessible and user-friendly notebook application for X heterozygosity analysis. XhetRel can serve as an initial quality control step in sequencing projects. Further investigating the source of X heterozygosity reveals the limitations of sequencing and variant calling methods in heterozygosity analysis. Our findings point to specific pseudogenes and gene clusters, such as SLC25A5 and GAGE cluster, as key contributors to erroneous variant allele fractions. Availability and implementation: Source code is available https://github.com/barslmn/XhetRel . Collab notebook can be accessed at https://colab.research.google.com/drive/1ep69JvXLwK5ndHUQ8qIGTWvauzsTW9fi .
Open AccessXhetRel: A Pipeline for X Heterozygosity and Relatedness Analysis in Sequencing Data
Motivation: Checking sample sex is one of the preliminary controls performed in genetic studies. Comparing multiple individuals and families in terms of sex and relatedness allows us to eliminate systematic errors in downstream analyses. While developing the pipeline we further delved into the origins of X heterozygosity by analysing the chromosome X variants from the 1000 Genomes Project. Result: We created an accessible and user-friendly notebook application for X heterozygosity analysis. XhetRel can serve as an initial quality control step in sequencing projects. Further investigating the source of X heterozygosity reveals the limitations of sequencing and variant calling methods in heterozygosity analysis. Our findings point to specific pseudogenes and gene clusters, such as SLC25A5 and GAGE cluster, as key contributors to erroneous variant allele fractions. Availability and implementation: Source code is available https://github.com/barslmn/XhetRel . Collab notebook can be accessed at https://colab.research.google.com/drive/1ep69JvXLwK5ndHUQ8qIGTWvauzsTW9fi .
- Open Access
- 5 January 2024
- Published by Wiley in Human Mutation
- Vol. 2024, 1-13
Macrocephaly and Digital Anomalies Expand the Phenotypic Spectrum of PGAP2 Variants in Hyperphosphatasia with Impaired Intellectual Development Syndrome 3 (HPMRS3)
Glycosylphosphatidylinositols (GPIs) anchor over 150 proteins as GPI-anchored proteins (GPI-APs) with crucial roles in diverse biological processes. The highly conserved biosynthesis of GPI-APs involves precise steps with at least 21 genes, categorized as PIG and PGAP genes. Pathogenic variants in these genes are linked to human diseases, highlighting the importance of each biosynthesis step. PGAP2 stands out among these genes due to its association with an expanded clinical spectrum of neurodevelopmental disorder (NDD) phenotypes with biallelic pathogenic variants. We present four patients from two families, one consanguineous and the other nonconsanguineous, each displaying distinct clinical presentations, including intellectual disability, hyperphosphatasia, hearing impairment, and epilepsy, as well as craniofacial and digital anomalies. Genetic analyses revealed homozygous and novel compound heterozygous missense variants in PGAP2 in four affected individuals, confirming the molecular diagnosis of hyperphosphatasia with impaired intellectual development syndrome 3 (HPMRS3). Importantly, the three amino acids affected by missense variants exhibit complete conservation in 10 vertebrate species, illuminating their crucial role in the genes functionality. Protein modeling provided additional evidence for the pathogenicity of the three substitutions, demonstrating their detrimental impact on protein folding and putative protein-protein interactions, ultimately leading to impaired protein function. The four patients in our study displayed common phenotypic features, such as brachydactyly, camptodactyly, and syndactyly, which have not been previously documented in individuals with PGAP2 variants. Notably, the occurrence of macrocephaly in two affected brothers from a consanguineous Pakistani family represents a novel finding. These previously unreported digital anomalies, along with macrocephaly and the identification of novel compound heterozygous variants, contribute to the expansion of the phenotypic and genotypic spectrum of HPMRS3 associated with PGAP2 variants.
- 5 January 2024
- Published by Wiley in Human Mutation
- Vol. 2024, 1-13
Open AccessMacrocephaly and Digital Anomalies Expand the Phenotypic Spectrum of PGAP2 Variants in Hyperphosphatasia with Impaired Intellectual Development Syndrome 3 (HPMRS3)
Glycosylphosphatidylinositols (GPIs) anchor over 150 proteins as GPI-anchored proteins (GPI-APs) with crucial roles in diverse biological processes. The highly conserved biosynthesis of GPI-APs involves precise steps with at least 21 genes, categorized as PIG and PGAP genes. Pathogenic variants in these genes are linked to human diseases, highlighting the importance of each biosynthesis step. PGAP2 stands out among these genes due to its association with an expanded clinical spectrum of neurodevelopmental disorder (NDD) phenotypes with biallelic pathogenic variants. We present four patients from two families, one consanguineous and the other nonconsanguineous, each displaying distinct clinical presentations, including intellectual disability, hyperphosphatasia, hearing impairment, and epilepsy, as well as craniofacial and digital anomalies. Genetic analyses revealed homozygous and novel compound heterozygous missense variants in PGAP2 in four affected individuals, confirming the molecular diagnosis of hyperphosphatasia with impaired intellectual development syndrome 3 (HPMRS3). Importantly, the three amino acids affected by missense variants exhibit complete conservation in 10 vertebrate species, illuminating their crucial role in the genes functionality. Protein modeling provided additional evidence for the pathogenicity of the three substitutions, demonstrating their detrimental impact on protein folding and putative protein-protein interactions, ultimately leading to impaired protein function. The four patients in our study displayed common phenotypic features, such as brachydactyly, camptodactyly, and syndactyly, which have not been previously documented in individuals with PGAP2 variants. Notably, the occurrence of macrocephaly in two affected brothers from a consanguineous Pakistani family represents a novel finding. These previously unreported digital anomalies, along with macrocephaly and the identification of novel compound heterozygous variants, contribute to the expansion of the phenotypic and genotypic spectrum of HPMRS3 associated with PGAP2 variants.
- 1 January 2024
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 63, 180-186
Novel Genetic Insights into Lateral Temporal Lobe Epilepsy: Findings from Whole Exome Sequencing
Lateral temporal lobe epilepsy (LTLE) is characterized by auditory auras and is often associated with genetic factors. Previous studies have identified various genes linked to LTLE, including LGI1. However, there remains a need to explore other genetic variants that contribute to the LTLE phenotype, particularly in the absence of LGI1 mutations. A cohort followed in our epilepsy center and diagnosed as LTLE with auditory aura was recruited to the study. We have performed whole exome sequencing data analysis of 19 patients using a two-step approach. In the first step, we have focused on six LTLE associated genes, namely LGI1, RELN, MICAL1, CNTNAP2, DEPDC5 and SCN1A. In the second step, the data was filtered against a list of epilepsy related genes. Our analysis identified novel variants in LTLE-associated genes, including RELN, SCN1A, and CNTNAP2, which confirmed previous findings. Importantly, for the first time, we identified a loss-of-function variation in the CHRNB2 gene that may be associated with the LTLE phenotype. Our study underscores the genetic heterogeneity of lateral temporal lobe epilepsy (LTLE) by identifying new genetic variants linked to the disorder. Notably, we propose that CHRNB2 is a novel gene associated with LTLE, thereby broadening the spectrum of known genetic contributors. This finding highlights the complexity of LTLE’s genetic landscape and suggests new pathways for future research and clinical application.
- 1 January 2024
- Published by Turk Noropsikiyatri Dernegi in Archives of Neuropsychiatry
- Vol. 63, 180-186
Novel Genetic Insights into Lateral Temporal Lobe Epilepsy: Findings from Whole Exome Sequencing
Lateral temporal lobe epilepsy (LTLE) is characterized by auditory auras and is often associated with genetic factors. Previous studies have identified various genes linked to LTLE, including LGI1. However, there remains a need to explore other genetic variants that contribute to the LTLE phenotype, particularly in the absence of LGI1 mutations. A cohort followed in our epilepsy center and diagnosed as LTLE with auditory aura was recruited to the study. We have performed whole exome sequencing data analysis of 19 patients using a two-step approach. In the first step, we have focused on six LTLE associated genes, namely LGI1, RELN, MICAL1, CNTNAP2, DEPDC5 and SCN1A. In the second step, the data was filtered against a list of epilepsy related genes. Our analysis identified novel variants in LTLE-associated genes, including RELN, SCN1A, and CNTNAP2, which confirmed previous findings. Importantly, for the first time, we identified a loss-of-function variation in the CHRNB2 gene that may be associated with the LTLE phenotype. Our study underscores the genetic heterogeneity of lateral temporal lobe epilepsy (LTLE) by identifying new genetic variants linked to the disorder. Notably, we propose that CHRNB2 is a novel gene associated with LTLE, thereby broadening the spectrum of known genetic contributors. This finding highlights the complexity of LTLE’s genetic landscape and suggests new pathways for future research and clinical application.
- 28 November 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (5) , 2271-2277
Two rare autosomal recessive neurological disorders identified by combined genetic approaches in a single consanguineous family with multiple offspring
Introduction Neurodevelopmental disorders (NDDs) refer to a broad range of diseases including developmental delay, intellectual disability, epilepsy, autism spectrum disorders, and attention-deficit/hyperactivity disorder caused by dysfunctions in tightly controlled brain development. The genetic backgrounds of NDDs are quite heterogeneous; to date, recessive or dominant variations in numerous genes have been implicated. Herein, we present a large consanguineous family from Turkiye, who has been suffering from NDDs with two distinct clinical presentations. Methods and results Combined in-depth genetic approaches led us to identify a homozygous frameshift variant in NALCN related to NDD and expansion of dodecamer repeat in CSTB related to Unverricht-Lundborg disease (ULD). Additionally, we sought to functionally analyze the NALCN variant in terms of mRNA expression level and current alteration. We have both detected a decrease in the level of premature stop codon-bearing mRNA possibly through nonsense-mediated mRNA decay mechanism and also an increased current in patch-clamp recordings for the expressed truncated protein. Conclusion In conclusion, increased consanguinity may lead to the revealing of distinct rare neurogenetic diseases in a single family. Exome sequencing is generally considered the first-tier diagnostic test in individuals with NDD. Yet we underline the fact that customized approaches other than exome sequencing may be used as in the case of ULD to aid diagnosis and better genetic counseling.
- 28 November 2023
- Published by Springer Nature in Neurological Sciences
- Vol. 45 (5) , 2271-2277
Two rare autosomal recessive neurological disorders identified by combined genetic approaches in a single consanguineous family with multiple offspring
Introduction Neurodevelopmental disorders (NDDs) refer to a broad range of diseases including developmental delay, intellectual disability, epilepsy, autism spectrum disorders, and attention-deficit/hyperactivity disorder caused by dysfunctions in tightly controlled brain development. The genetic backgrounds of NDDs are quite heterogeneous; to date, recessive or dominant variations in numerous genes have been implicated. Herein, we present a large consanguineous family from Turkiye, who has been suffering from NDDs with two distinct clinical presentations. Methods and results Combined in-depth genetic approaches led us to identify a homozygous frameshift variant in NALCN related to NDD and expansion of dodecamer repeat in CSTB related to Unverricht-Lundborg disease (ULD). Additionally, we sought to functionally analyze the NALCN variant in terms of mRNA expression level and current alteration. We have both detected a decrease in the level of premature stop codon-bearing mRNA possibly through nonsense-mediated mRNA decay mechanism and also an increased current in patch-clamp recordings for the expressed truncated protein. Conclusion In conclusion, increased consanguinity may lead to the revealing of distinct rare neurogenetic diseases in a single family. Exome sequencing is generally considered the first-tier diagnostic test in individuals with NDD. Yet we underline the fact that customized approaches other than exome sequencing may be used as in the case of ULD to aid diagnosis and better genetic counseling.
- 22 November 2023
- Published by Galenos Yayinevi in Archives Of Epilepsy
- Vol. 29 (4) , 121-125
Epilepsy Spectrum Associated with PRRT2 Variants: Case Presentations
- 22 November 2023
- Published by Galenos Yayinevi in Archives Of Epilepsy
- Vol. 29 (4) , 121-125
Epilepsy Spectrum Associated with PRRT2 Variants: Case Presentations
- 4 May 2023
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 134 (10) , 1040-1045
Targeted resequencing reveals high-level mosaicism for a novel frameshift variant in WDR45 associated with beta-propeller protein-associated neurodegeneration
Beta-propeller protein-associated neurodegeneration (BPAN) is a rare X-linked dominant neurodegenerative disease, which is characterized by iron accumulation in the basal ganglia. BPAN is associate...
- 4 May 2023
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 134 (10) , 1040-1045
Targeted resequencing reveals high-level mosaicism for a novel frameshift variant in WDR45 associated with beta-propeller protein-associated neurodegeneration
Beta-propeller protein-associated neurodegeneration (BPAN) is a rare X-linked dominant neurodegenerative disease, which is characterized by iron accumulation in the basal ganglia. BPAN is associate...
- 6 April 2023
- Published by Turkish Academy of Sciences
- p. 379-396
Nörogenetik
Approximately 5 million individuals in Turkey have been afflicted with a rare disease. Difficulties experienced from diagnosis to treatment of rare diseases can only be solved with long-term, multidisciplinary and personalized approaches. Since neurological involvement is observed in at least half of all rare diseases, neurogenetic diseases constitute an important model in the context of rare disease research. The practical use of next-generation sequencing (NGS) technologies has made it possible to determine the heterogeneous genetic background of neurogenetic diseases. NGS oriented personalized and accessible genetic diagnosis has enabled characterization of de novo and mosaic variations, and demonstrated the genotype-phenotype relationships on a large scale. These milestones in the diagnosis of neurogenetic diseases have also been a light of hope for the treatment options. In particular, the rapid development of CRISPR-based gene editing technologies and high-efficiency gene transfer strategies in paralel with NGS have paved the way for new generation molecular treatments.
- 6 April 2023
- Published by Turkish Academy of Sciences
- p. 379-396
Nörogenetik
Approximately 5 million individuals in Turkey have been afflicted with a rare disease. Difficulties experienced from diagnosis to treatment of rare diseases can only be solved with long-term, multidisciplinary and personalized approaches. Since neurological involvement is observed in at least half of all rare diseases, neurogenetic diseases constitute an important model in the context of rare disease research. The practical use of next-generation sequencing (NGS) technologies has made it possible to determine the heterogeneous genetic background of neurogenetic diseases. NGS oriented personalized and accessible genetic diagnosis has enabled characterization of de novo and mosaic variations, and demonstrated the genotype-phenotype relationships on a large scale. These milestones in the diagnosis of neurogenetic diseases have also been a light of hope for the treatment options. In particular, the rapid development of CRISPR-based gene editing technologies and high-efficiency gene transfer strategies in paralel with NGS have paved the way for new generation molecular treatments.